Discontinued — last reported Q3 '20
Amgen Finite-Lived Intangible Assets - Expected Amortization Expense (Year Two) decreased by 2.7% to $3.60B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.7%, from $3.90B to $3.60B. This is a positive signal — lower values indicate better performance for this metric.
Consistent or declining amortization schedules provide predictability for future earnings, whereas spikes may indicate large, recent asset acquisitions.
This is the projected expense for the second year following the balance sheet date related to the systematic write-down...
Standard forward-looking disclosure used by analysts to build multi-year financial models and earnings projections.
finite_lived_intangible_assets_amortization_year_2| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.80B | $1.80B | $1.70B | $1.70B | $2.40B | $2.50B | $2.50B | $2.50B | $3.90B | $3.90B | $3.90B | $3.70B | $3.70B | $3.60B |
| QoQ Change | — | +0.0% | -5.6% | +0.0% | +41.2% | +4.2% | +0.0% | +0.0% | +56.0% | +0.0% | +0.0% | -5.1% | +0.0% | -2.7% |
| YoY Change | — | — | — | -5.6% | +33.3% | +47.1% | +47.1% | +4.2% | +56.0% | +56.0% | +56.0% | -5.1% | -5.1% | -7.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.